The effect of hemolysis on quality control metrics for noninvasive prenatal testing.
Yaya GuoDandan YuKaisu ZhouJie WangDongzhu LeiZhenpeng XuWeijiang TangMiaofeng WuXingxing FangJiankun ShenZhiyu PengJiale XiangPublished in: BMC medical genomics (2022)
For NIPT using massively parallel sequencing, samples with slight or moderate hemolysis (≤ 4 g/L) are acceptable. However, careful consideration should be taken regarding the use of severely hemolyzed samples (> 4 g/L), since they might increase the risk of test failure.